Pharmacovigilance and clinical environment: utilizing OMOP-CDM and OHDSI software stack to integrate EHR data

VK Dimitriadis, GI Gavriilidis… - Public Health and …, 2021 - ebooks.iospress.nl
Abstract Information Technology (IT) and specialized systems could have a prominent role
towards the support of drug safety processes, both in the clinical context but also beyond …

[PDF][PDF] Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data

J Mantas - 2021 - pdfs.semanticscholar.org
Information Technology (IT) and specialized systems could have a prominent role towards
the support of drug safety processes, both in the clinical context but also beyond that …

[PDF][PDF] Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data

J Mantas - 2021 - academia.edu
Information Technology (IT) and specialized systems could have a prominent role towards
the support of drug safety processes, both in the clinical context but also beyond that …

[PDF][PDF] Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data

J Mantas - 2021 - scholar.archive.org
Information Technology (IT) and specialized systems could have a prominent role towards
the support of drug safety processes, both in the clinical context but also beyond that …

Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data.

VK Dimitriadis, GI Gavriilidis… - Studies in Health …, 2021 - europepmc.org
Information Technology (IT) and specialized systems could have a prominent role towards
the support of drug safety processes, both in the clinical context but also beyond that …

Pharmacovigilance and Clinical Environment: Utilizing OMOP-CDM and OHDSI Software Stack to Integrate EHR Data

VK Dimitriadis, GI Gavriilidis… - Studies in health …, 2021 - pubmed.ncbi.nlm.nih.gov
Information Technology (IT) and specialized systems could have a prominent role towards
the support of drug safety processes, both in the clinical context but also beyond that …